Trellis Bioscience, Inc.
Publicly observedRedwood City, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Redwood City | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Trellis Bioscience, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | LFEJER34NQU6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Aug 2026Publicly observed
NIH SBIR/STTR award: Human Antibody for Acute Infection Treatment of RSV
USD 999,759.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant18 Jul 2024Publicly observed
NIH SBIR/STTR award: Bacterial Pneumonia Therapeutic Antibody Safety Trial
USD 998,879.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.